These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31637306)

  • 1. PBF, a Proto-oncogene in Esophageal Carcinoma.
    Lian SH; Song JD; Huang Y
    Open Med (Wars); 2019; 14():748-756. PubMed ID: 31637306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRDX2 plays an oncogenic role in esophageal squamous cell carcinoma via Wnt/β-catenin and AKT pathways.
    Feng AL; Han X; Meng X; Chen Z; Li Q; Shu W; Dai H; Zhu J; Yang Z
    Clin Transl Oncol; 2020 Oct; 22(10):1838-1848. PubMed ID: 32130676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic role of LYN in human gastric cancer via the Wnt/β-catenin and AKT/mTOR pathways.
    Su R; Zhang J
    Exp Ther Med; 2020 Jul; 20(1):646-654. PubMed ID: 32509024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake.
    Smith VE; Franklyn JA; McCabe CJ
    J Endocrinol; 2011 Aug; 210(2):157-63. PubMed ID: 21450804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma.
    Zhang Y; Zhang J; Pan G; Guan T; Zhang C; Hao A; Li Y; Ren H
    World J Surg Oncol; 2021 Aug; 19(1):242. PubMed ID: 34399788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD155 Cooperates with PD-1/PD-L1 to Promote Proliferation of Esophageal Squamous Cancer Cells via PI3K/Akt and MAPK Signaling Pathways.
    Tang X; Yang J; Shi A; Xiong Y; Wen M; Luo Z; Tian H; Zheng K; Liu Y; Shu C; Ma N; Wang R; Zhao J
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.
    McCabe CJ; Khaira JS; Boelaert K; Heaney AP; Tannahill LA; Hussain S; Mitchell R; Olliff J; Sheppard MC; Franklyn JA; Gittoes NJ
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):141-50. PubMed ID: 12580928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway.
    Shu J; Huang M; Tian Q; Shui Q; Zhou Y; Chen J
    J Mol Histol; 2015 Apr; 46(2):157-71. PubMed ID: 25564356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers.
    Reddy D; Kumavath R; Tan TZ; Ampasala DR; Kumar AP
    Life Sci; 2020 Jan; 241():117147. PubMed ID: 31830480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma.
    Yan S; Zhou C; Lou X; Xiao Z; Zhu H; Wang Q; Wang Y; Lu N; He S; Zhan Q; Liu S; Xu N
    Cancer Res; 2009 Apr; 69(8):3283-90. PubMed ID: 19351864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
    Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
    Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary tumor transforming gene binding factor (PBF) is required for androgen-induced prostate cancer proliferation and invasion.
    Huang SQ; Wang B; Liao QJ; Shen CX; Li WB
    Neoplasma; 2019 May; 66(3):327-335. PubMed ID: 30569723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis.
    Stratford AL; Boelaert K; Tannahill LA; Kim DS; Warfield A; Eggo MC; Gittoes NJ; Young LS; Franklyn JA; McCabe CJ
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4341-9. PubMed ID: 15886233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma.
    Zhou C; Liu S; Zhou X; Xue L; Quan L; Lu N; Zhang G; Bai J; Wang Y; Liu Z; Zhan Q; Zhu H; Xu N
    Int J Cancer; 2005 Mar; 113(6):891-8. PubMed ID: 15514942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.